Autocrine and Paracrine Regulation of the Ovary

  • Marta Tesone
  • Dalhia Abramovich
  • Griselda Irusta
  • Fernanda Parborell

Ovarian follicular development and regression is a continuous and cyclic process that depends on a number of endocrine, paracrine, and autocrine signals. Although many of the factors involved in follicular growth have been characterized, it remains unknown why one or more, depending on species, preovulatory follicle(s) emerge as dominant and the others regress. It is postulated that the selected dominant follicle(s) possesses a higher sensitivity to FSH due to increased expression of FSH receptors. As a result, increases in estradiol and inhibin trigger a negative feedback mechanism that prevents the other follicles from continuing their development. The ovarian theca and granulosa cells also play an important role, since they produce steroid hormones required for normal follicular growth. In addition, ovarian growth factors, cytokines, and neuropeptides participate as regulators of follicular growth and in the formation of the ovarian cell compartments as well.


Granulosa Cell Corpus Luteum Antral Follicle Follicular Development GnRH Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


21.6Glossary of Terms and Acronyms


anti-Müllerian hormone


angiopoietin 1


angiopoietin 2


angiopoietin 3


angiopoietin 4


basic fibroblastic growth factor


bone morphogenetic protein


epidermal growth factor


fibroblastic growth factor


follicle-stimulating hormone


γ-aminobutyric acid


growth and differentiation factors


neurotrophic factors derived from glial cells


gonadotroping releasing hormone


gonadotroping releasing hormone agonist


human Chorionic Gonadotropin


insulin like growth factor binding protein


insulin like growth factor-I


insulin like growth factor-II


luteinizing hormone


nerve growth factor


neurotrophin 4/5


steroidogenic acute regulatory protein


transforming growth factor alpha


transforming growth factor


angiopoietin receptor type 1


angiopoietin receptor type 2


VEGF antagonist


vascular endothelial growth factor

VEGFR1 or Flt-1:

vascular endothelial growth factor receptor type 1

VEGFR2 or Flk-1/KDR:

vascular endothelial growth factor receptor type 2


  1. 1.
    McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000; 21:200–14.PubMedCrossRefGoogle Scholar
  2. 2.
    Zeleznik AJ, Schuler HM, Reichert LE, Jr. Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology 1981; 109:356–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Zeleznik AJ, Midgley AR, Jr., Reichert LE, Jr. Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology 1974; 95:818–25.PubMedCrossRefGoogle Scholar
  4. 4.
    Wang XN, Greenwald GS. Synergistic effects of steroids with FSH on folliculogenesis, steroidogenesis and FSH- and hCG-receptors in hypophysectomized mice. J Reprod Fertil 1993; 99:403–13.PubMedCrossRefGoogle Scholar
  5. 5.
    Vitale AM, Gonzalez OM, Parborell F, et al. Inhibin a increases apoptosis in early ovarian antral follicles of diethylstilbestrol-treated rats. Biol Reprod 2002; 67:1989:95.PubMedCrossRefGoogle Scholar
  6. 6.
    McNatty KP, Makris A, DeGrazia C, et al. The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro. J Clin Endocrinol Metab 1979; 49:687–99.PubMedCrossRefGoogle Scholar
  7. 7.
    McGee EA. The regulation of apoptosis in preantral ovarian follicles. Biol Signals Recept 2000; 9:81–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Hillier SG, van den Boogaard AM, Reichert LE, Jr., et al. Alterations in granulosa cell aromatase activity accompanying preovulatory follicular development in the rat ovary with evidence that 5alpha-reduced C19 steroids inhibit the aromatase reaction in vitro. J Endocrinol 1980; 84:409–19.PubMedCrossRefGoogle Scholar
  9. 9.
    McNatty KP. Regulation of follicle maturation in the human ovary: a role for 5-reduced androgens. In: Cumming IA FJMF, editor. Endocrinology. Camberra: Australian Academy of Sciences, 1980:1–51.Google Scholar
  10. 10.
    Moon YS, Tsang BK, Simpson C, et al. 17 beta-Estradiol biosynthesis in cultured granulosa and thecal cells of human ovarian follicles: stimulation by follicle-stimulating hormone. J Clin Endocrinol Metab 1978; 47:263–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Fortune JE, Armstrong DT. Androgen production by theca and granulosa isolated from proestrous rat follicles. Endocrinology 1977; 100:1341–7.CrossRefGoogle Scholar
  12. 12.
    Ashkenazi H, Cao X, Motola S, et al. Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology 2005; 146:77–84.PubMedCrossRefGoogle Scholar
  13. 13.
    De Celis JF, Mari-Beffa M, Garcia-Bellido A. Cell-autonomous role of Notch, an epidermal growth factor homologue, in sensory organ differentiation in Drosophila. Proc Natl Acad Sci U S A 1991; 88:632–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Maruo T, Ladines-Llave CA, Samoto T, et al. Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression. Endocrinology 1993; 132: 924–31.PubMedCrossRefGoogle Scholar
  15. 15.
    Tilly JL, Billig H, Kowalski KI, et al. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol Endocrinol 1992; 6: 1942–50.PubMedCrossRefGoogle Scholar
  16. 16.
    Yeh J, Yeh YC. Transforming growth factor-alpha and human cancer. Biomed Pharmacother 1989; 43:651–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Tsafriri A, Adashi EY. Local nonsteroidal regulators of ovarian function. In: Knovil E, Neill J, editors. The Physiology of Reproduction. New York: Raven Press Ltd, 1994: 817–43.Google Scholar
  18. 18.
    Kudlow JE, Kobrin MS, Purchio AF, et al. Ovarian transforming growth factor-alpha gene expression: immunohistochemical localization to the theca-interstitial cells. Endocrinology 1987; 121:1577–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Oliver JE, Aitman TJ, Powell JF, et al. Insulin-like growth factor I gene expression in the rat ovary is confined to the granulosa cells of developing follicles. Endocrinology 1989; 124:2671–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Hsueh AJ, Billig H, Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 1994; 15:707–24.PubMedGoogle Scholar
  21. 21.
    el Roeiy A, Chen X, Roberts VJ, et al. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 1994; 78:1488–96.PubMedCrossRefGoogle Scholar
  22. 22.
    Geisthovel F, Moretti-Rojas I, Asch RH, et al. Expression of insulin-like growth factor-II (IGF-II) messenger ribonucleic acid (mRNA), but not IGF-I mRNA, in human preovulatory granulosa cells. Hum Reprod 1989; 4:899–02.PubMedGoogle Scholar
  23. 23.
    Iwashita M, Kudo Y, Yoshimura Y, et al. Physiological role of insulin-like-growth-factor-binding protein-4 in human folliculogenesis. Horm Res 1996; 46:31–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Erickson GF, Nakatani A, Ling N, et al. Localization of insulin-like growth factor-binding protein-5 messenger ribonucleic acid in rat ovaries during the estrous cycle. Endocrinology 1992; 130: 1867–78.PubMedCrossRefGoogle Scholar
  25. 25.
    Chun SY, Billig H, Tilly JL, et al. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor I. Endocrinology 1994; 135:1845–53.PubMedCrossRefGoogle Scholar
  26. 26.
    Armstrong DG, Webb R. Ovarian follicular dominance: the role of intraovarian growth factors and novel proteins. Rev Reprod 1997; 2:139–46.PubMedCrossRefGoogle Scholar
  27. 27.
    Chegini N, Williams RS. Immunocytochemical localization of transforming growth factors (TGFs) TGF-alpha and TGF-beta in human ovarian tissues. J Clin Endocrinol Metab 1992; 74:973–80.PubMedCrossRefGoogle Scholar
  28. 28.
    Li S, Maruo T, Ladines-Llave CA, et al. Expression of transforming growth factor-alpha in the human ovary during follicular growth, regression and atresia. Endocr J 1994; 41:693–01.PubMedCrossRefGoogle Scholar
  29. 29.
    Drummond AE. TGFbeta signalling in the development of ovarian function. Cell Tissue Res 2005; 322:107–15.PubMedCrossRefGoogle Scholar
  30. 30.
    Magoffin DA, Gancedo B, Erickson GF. Transforming growth factor-beta promotes differentiation of ovarian thecal-interstitial cells but inhibits androgen production. Endocrinology 1989; 125:1951–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction 2006; 132:191–06.PubMedCrossRefGoogle Scholar
  32. 32.
    Cook RW, Thompson TB, Jardetzky TS, et al. Molecular biology of inhibin action. Semin Reprod Med 2004; 22:269–76.PubMedCrossRefGoogle Scholar
  33. 33.
    Drummond AE, Le MT, Ethier JF, et al. Expression and localization of activin receptors, Smads, and beta glycan to the postnatal rat ovary. Endocrinology 2002; 143:1423–33.PubMedCrossRefGoogle Scholar
  34. 34.
    Silva CC, Groome NP, Knight PG. Immunohistochemical localization of inhibin/activin alpha, betaA and betaB subunits and follistatin in bovine oocytes during in vitro maturation and fertilization. Reproduction 2003; 125:33–42.PubMedCrossRefGoogle Scholar
  35. 35.
    Dodson WC, Schomberg DW. The effect of transforming growth factor-beta on follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology 1987; 120:512–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Di Blasio AM, Vigano P, Cremonesi L, et al. Expression of the genes encoding basic fibroblast growth factor and its receptor in human granulosa cells. Mol Cell Endocrinol 1993; 96:R7–11.PubMedCrossRefGoogle Scholar
  37. 37.
    Tapanainen J, Leinonen PJ, Tapanainen P, et al. Regulation of human granulosa-luteal cell progesterone production and proliferation by gonadotropins and growth factors. Fertil Steril 1987; 48:576–80.PubMedGoogle Scholar
  38. 38.
    Chun SY, Eisenhauer KM, Minami S, et al. Growth factors in ovarian follicle atresia. Semin Reprod Endocrinol 1996; 14:197–02.PubMedCrossRefGoogle Scholar
  39. 39.
    Berisha B, Schams D. Ovarian function in ruminants. Domest Anim Endocrinol 2005; 29:305–17.PubMedCrossRefGoogle Scholar
  40. 40.
    Mayerhofer A, Smith GD, Danilchik M, et al. Oocytes are a source of catecholamines in the primate ovary: evidence for a cell-cell regulatory loop. Proc Natl Acad Sci U S A 1998; 95:10990–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Fritz S, Wessler I, Breitling R, et al. Expression of muscarinic receptor types in the primate ovary and evidence for nonneuronal acetylcholine synthesis. J Clin Endocrinol Metab 2001; 86: 349–54.PubMedCrossRefGoogle Scholar
  42. 42.
    Fritz S, Fohr KJ, Boddien S, et al. Functional and molecular characterization of a muscarinic receptor type and evidence for expression of choline-acetyltransferase and vesicular acetylcholine transporter in human granulosa-luteal cells. J Clin Endocrinol Metab 1999; 84:1744–50.PubMedCrossRefGoogle Scholar
  43. 43.
    Fritz S, Grunert R, Stocco DM, et al. StAR protein is increased by muscarinic receptor activation in human luteinized granulosa cells. Mol Cell Endocrinol 2001; 171:49–51.PubMedCrossRefGoogle Scholar
  44. 44.
    Erdo S, Varga B, Horvath E. Effect of local GABA administration on rat ovarian blood flow, and on progesterone and estradiol secretion. Eur J Pharmacol 1985; 111:397–400.PubMedCrossRefGoogle Scholar
  45. 45.
    McNeill DL, Burden HW. Neuropeptide Y and somatostatin immunoreactive perikarya in preaortic ganglia projecting to the rat ovary. J Reprod Fertil 1986; 78:727–32.Google Scholar
  46. 46.
    McNeill DL, Burden HW. Peripheral pathways for neuropeptide Y- and cholecystokinin-8-immunoreactive nerves innervating the rat ovary. Neurosci Lett 1987; 80:27–32.PubMedCrossRefGoogle Scholar
  47. 47.
    Dissen GA, Hirshfield AN, Malamed S, et al. Expression of neurotrophins and their receptors in the mammalian ovary is developmentally regulated: changes at the time of folliculogenesis. Endocrinology 1995; 136:4681–92.PubMedCrossRefGoogle Scholar
  48. 48.
    Matzuk MM, Burns KH, Viveiros MM, et al. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 2002; 296:2178–80.PubMedCrossRefGoogle Scholar
  49. 49.
    Mayerhofer A, Dissen GA, Parrott JA, et al. Involvement of nerve growth factor in the ovulatory cascade: trkA receptor activation inhibits gap junctional communication between thecal cells. Endocrinology 1996; 137:5662–70.PubMedCrossRefGoogle Scholar
  50. 50.
    Hsueh AJ, Jones PB. Extrapituitary actions of gonadotropin-releasing hormone. Endocr Rev 1981; 2:437–61.PubMedCrossRefGoogle Scholar
  51. 51.
    Guerrero HE, Stein P, Asch RH, et al. Effect of a gonadotropin-releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells. Fertil Steril 1993; 59:803–88.PubMedGoogle Scholar
  52. 52.
    Kang SK, Tai CJ, Nathwani PS, et al. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells. Endocrinology 2001; 142:182–92.PubMedCrossRefGoogle Scholar
  53. 53.
    Andreu C, Parborell F, Vanzulli S, et al. Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: relationship between steroidogenesis and apoptosis. Mol Reprod Dev 1998; 51:287–94.PubMedCrossRefGoogle Scholar
  54. 54.
    Sridaran R, Philip GH, Li H, et al. GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy. J Mol Endocrinol 1999; 22:45–54.PubMedCrossRefGoogle Scholar
  55. 55.
    Parborell F, Dain L, Tesone M. Gonadotropin-releasing hormone agonist affects rat ovarian follicle development by interfering with FSH and growth factors on the prevention of apoptosis. Mol Reprod Dev 2001; 60:241–7.PubMedCrossRefGoogle Scholar
  56. 56.
    Parborell F, Irusta G, Vitale AM, et al. GnRH antagonist Antide inhibits apoptosis of preovulatory follicle cells in rat ovary. Biol Repr 2005; 72:659–66.CrossRefGoogle Scholar
  57. 57.
    Parborell F, Pecci A, Gonzalez O, et al. Effects of a gonadotropin-releasing hormone agonist on rat ovarian follicle apoptosis: Regulation by EGF and the expression of Bcl-2-related genes. Biol Reprod 2002; 67:481–6.PubMedCrossRefGoogle Scholar
  58. 58.
    Irusta G, Parborell F, Peluffo M, et al. Steroidogenic acute regulatory protein in ovarian follicles of gonadotropin-stimulated rats is regulated by a gonadotropin-releasing hormone agonist. Biol Reprod 2003; 68:1577–83.PubMedCrossRefGoogle Scholar
  59. 59.
    Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 1996; 7:259–70.Google Scholar
  60. 60.
    Reynolds LP, Grazul-Bilska AT, Killilea SD, et al. Mitogenic factors of corpora lutea. Prog Growth Factor Res 1994; 5:159–75.Google Scholar
  61. 61.
    Stouffer RL, Martinez-Chequer JC, Molskness TA, et al. Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 2001; 32:567–75.PubMedCrossRefGoogle Scholar
  62. 62.
    Tamanini C, De Ambrogi M. Angiogenesis in developing follicle and corpus luteum. Reprod Domest Anim 2004; 39:206–16.PubMedCrossRefGoogle Scholar
  63. 63.
    Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000; 74:429–38.PubMedCrossRefGoogle Scholar
  64. 64.
    Berisha B, Schams D, Kosmann M, et al. Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles. J Endocrinol 2000; 167:371–82.PubMedCrossRefGoogle Scholar
  65. 65.
    Celik-Ozenci C, Akkoyunlu G, Kayisli UA, et al. Localization of vascular endothelial growth factor in the zona pellucida of developing ovarian follicles in the rat: a possible role in destiny of follicles. Histochem Cell Biol 2003; 120:383–90.PubMedCrossRefGoogle Scholar
  66. 66.
    Redmer DA, Doraiswamy V, Bortnem BJ, et al. Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum. Biol Reprod 2001; 65:879–89.PubMedCrossRefGoogle Scholar
  67. 67.
    Jakeman LB, Winer J, Bennett GL, et al. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 1992; 89:244–53.PubMedCrossRefGoogle Scholar
  68. 68.
    Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55–60.PubMedCrossRefGoogle Scholar
  69. 69.
    Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87:1161–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87:1171–80.PubMedCrossRefGoogle Scholar
  71. 71.
    Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997; 277:48–50.PubMedCrossRefGoogle Scholar
  72. 72.
    Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Valenzuela DM, Griffiths JA, Rojas J, et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A 1999; 96:1904–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Zimmermann RC, Hartman T, Kavic S, et al. Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest 2003; 112:659–69.PubMedGoogle Scholar
  75. 75.
    Wulff C, Wilson H, Wiegand SJ, et al. Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. Endocrinology 2002; 143:2797–807.PubMedCrossRefGoogle Scholar
  76. 76.
    Hazzard TM, Xu F, Stouffer RL. Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys. Biol Reprod 2002; 67:1305–12.PubMedCrossRefGoogle Scholar
  77. 77.
    Abramovich D, Parborell F, Tesone M. Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats. Biol Reprod 2006; 75:434–41.PubMedCrossRefGoogle Scholar
  78. 78.
    Parborell F, Abramovich D, Tesone M. Intrabursal Administration of the Antiangiopoietin 1 Antibody Produces a Delay in Rat Follicular Development Associated with an Increase in Ovarian Apoptosis Mediated by Changes in the Expression of BCL2 Related Genes. Biol Reprod 2007; 78: 506–13.PubMedCrossRefGoogle Scholar
  79. 79.
    Xu F, Hazzard TM, Evans A, et al. Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys. Contraception 2005; 71: 239–48.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Marta Tesone
    • 1
  • Dalhia Abramovich
    • 1
  • Griselda Irusta
    • 1
  • Fernanda Parborell
    • 1
  1. 1.Institute of Experimental Biology and Medicine-CONICETBuenos AiresArgentina

Personalised recommendations